The best of Cambridge UK life science businesses are making encouraging headway commercially in the US and Artios Pharma’s latest move looks set to provide another ‘wow’ moment on both sides of the Pond.
Artios has just hired biopharma industry class act Christine Silverstein as Chief Financial Officer. As CEO Niall Martin remarks, her track record of raising capital, preparing companies for IPO and experience with partnerships and M & A will position Artios for success as it continues to advance its leading DNA damage response (DDR) pipeline.
To read more: https://www.businessweekly.co.uk/posts/silverstein-appointed-chief-financial-officer-at-artios-pharma